Volume 12, Issue 3 (autumn 2004)                   JSSU 2004, 12(3): 71-77 | Back to browse issues page

XML Persian Abstract Print


Abstract:   (10267 Views)
Introduction: Secondry Prevention is Very important in breast cancer because when treatment is started,the breast mass will have smaler size. One of the most important way For Secondry Prevention of breast cancer is examination by Physician or health care provider. Materials and Methods: In this Quasi experimental study that aimd to evaluating the effect of education about importance of CBE on attendance of kermanian teacher woman for examination, 501 subjects Participated. Schools were selected by multistage random sampling Method and divided in to experimental and control groups. An educational pamphelet were given to the experimental group and both groups were Informed about address and date of attendance. After two months an investigator-made questionnaire were responded by all of teachers. Results: The results showed there was not significant differences in two groups according to those variables Could be probably effective on attendance, with exception of mariage status and education level . The attendance rate for CBE in experimental grorp (17.3%) was Significantly (p<0.001) higher than control (6%). The relationships between attendance rate with Personal characteristics and variables related to breast Cancer revealed the significant difference with history of breast cancer in Family only in experimental group (p<0.05) ,so that the attendance rate in teachers with positive history were higher. Conclusion: Although the attendanee rate is not stisfactory in two groups but using the educational pamphelet that is simple, Not expensive and needless to direct contact with educator, attendance rate in experimental group was three time higher than control group
Full-Text [PDF 181 kb]   (2042 Downloads)    
Type of Study: Original article | Subject: General
Received: 2010/12/6 | Published: 2004/10/15

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.